Medidata is more than an innovative tech company. We sit at the intersection of Technology and Life Sciences industries, and are a founder-led community of passionate people who are transforming clinical development. We’re taking the lead and demonstrating the possibilities of what cloud technology can do to make the science of drug development better, improving the lives of patients everywhere. 

With our singular focus on clinical development in life sciences, our team provides applications, analytics and benchmarks that not only make current trial processes run better, but also transform them to be more efficient, productive and streamlined. Medidata is committed to providing all members of the clinical team—researchers, clinicians and patients—with the most advanced tools for planning and managing their clinical studies, generating value for by powering trials that run faster, have less risk, higher quality and require fewer resources. That means better treatments can reach waiting patients sooner. We are publicly traded (MDSO) with over 900 customers, customer retention rates above 98%, and the experience of supporting more than 13,000 clinical trials. We are still led by Co-founders, Tarek Sherif and Glen de Vries, and have global operations in US, Europe and Asia.